फार्मास्यूटिकल्स
Gurugram fake Mounjaro racket busted: Two arrested, Rs 71 lakh seized, nationwide alert issued
AI द्वारा रिपोर्ट किया गया AI द्वारा उत्पन्न छवि
Gurugram's Drugs Control Office busted a counterfeit Mounjaro (tirzepatide) injections racket on April 18, arresting Avi Sharma and Mujammil Khan after intercepting a cab in DLF Phase-IV and raiding Sharma's flat. Fake injections worth over Rs 71 lakh were seized, with packaging machines recovered. A nationwide alert has been issued, and officials warn of health risks from such fakes.
Executives at West Pharmaceutical Services revealed details of a recent cybersecurity breach during a fireside chat at the Bank of America Global Healthcare Conference. The company issued an 8-K filing the previous evening after detecting an intruder in its systems. Officials described shutting down global operations to assess the situation.
AI द्वारा रिपोर्ट किया गया
Verrica Pharmaceuticals Inc. conducted its first quarter 2026 earnings conference call on May 12.
Syntara Limited held a shareholder webinar on April 29 to discuss FDA feedback on its proposed Phase IIb trial for amsulostat in myelofibrosis, along with a capital raise and quarterly report. CEO Gary Phillips highlighted the agreed path forward with regulators. The company lodged its Appendix 4C quarterly with the ASX.
AI द्वारा रिपोर्ट किया गया तथ्य-जाँच किया गया
University of Utah scientists report that a radical SAM enzyme known as PapB can join the ends of certain therapeutic peptides to form stable, ring-shaped structures. In experiments described in ACS Bio & Med Chem Au, the enzyme macrocyclized GLP-1-like peptides—including versions containing nonstandard amino acids found in some modern incretin drugs—an approach the researchers say could help make GLP-1 medicines such as semaglutide (Ozempic and Wegovy) more resistant to breakdown.
The US Food and Drug Administration approved Foundayo, a new once-daily pill for obesity treatment, on Wednesday. Eli Lilly, the manufacturer, also produces the weight-loss injection Zepbound. The approval positions Foundayo as the second obesity pill cleared by the FDA.
AI द्वारा रिपोर्ट किया गया
Researchers from Mass General Brigham found that the cholesterol drug evolocumab cuts the risk of first-time major cardiovascular events by 31% in high-risk patients with diabetes who lack diagnosed atherosclerosis. The results, from a subgroup analysis of the VESALIUS-CV trial, were presented at the American College of Cardiology's Annual Scientific Session and published in JAMA. Patients on the drug saw LDL cholesterol levels drop significantly alongside standard treatments.
Semaglutide shows strong weight loss results for adults over 65
06 मई 2026 18:37Acadia Pharmaceuticals publishes 2026 Q1 earnings slide deck
05 मई 2026 05:13Egypt's industry minister meets pharma chamber to boost growth, exports
04 मई 2026 23:53Biontech to close nearly all production sites in Germany
04 मई 2026 23:12Pharco Pharmaceuticals plans EGP 1.5bn investments for production and export expansion
27 अप्रैल 2026 15:38Egypt and Kenya deepen health and pharmaceutical cooperation at Nairobi summit
26 अप्रैल 2026 12:25Sun Pharma shares jump over 9% on $11.75 billion Organon acquisition
22 अप्रैल 2026 02:24Pharco launches EGP 500m eye drops production line in Alexandria
13 अप्रैल 2026 22:13FDA approves Travere Therapeutics' FILSPARI for FSGS
02 अप्रैल 2026 19:20Trump administration adjusts metal tariffs, imposes 100% pharmaceutical duty